Analyzing Capital Efficiency: Stoke Therapeutics, Inc. (NASDAQ: STOK) Outperforms Biopharma Peers in ROIC/WACC
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRetail Opportunity Investments Corp.
-
Registration countryUSA
-
IndustryReal Estate Investment and Services
-
М/S&P/F
*** /*** /***









